TG2 exists in two isoforms, generated by alternative splicing, with opposing roles: TG2-L, which supports cell survival and contributes to tumour progression and chemoresistance, and TG2-S, which promotes cell death and may act as a tumour suppressor [9,10]. The gene discussed is TGM2; the disease is neoplasm.